Amgen's earnings beat, but analysts spooked by falling product sales; Boehringer powers 2012 sales to €14.7B, an 11.4% jump;

@FiercePharma: More on GSK's first-quarter numbers to come. For now, sales down 2% to £6.5 bn. Release | Follow @FiercePharma

@EricPFierce: FDA thinks a computer system can help it identify which plants are at most risk & should top list for inspections. More | Follow @EricPFierce

> Amgen's ($AMGN) first-quarter earnings beat expectations at $1.91 per share, partly on lower taxes, but its $4.24 billion in sales fell short as several of its key products lost ground. Release | Report

> Boehringer Ingelheim posted an 11.5% increase in annual sales to about €14.7 billion in 2012, and it expects mid-single-digit growth this year, executives said during an annual year-in-review press conference. Release

> Teva Pharmaceutical Industries ($TEVA) created a new division to manage its specialty drugs and tapped Rob Koremans, currently a Teva director, to lead that business. Report

> The FDA plans a study to determine whether corrective consumer advertising actually works to change misconceptions caused by previously deficient ads. Report

> AstraZeneca ($AZN) launched its first mobile app on the corporate side, aimed at keeping investors abreast of company news and developments. Report

> Ironwood Pharmaceuticals ($IRWD) shares slid after the company posted a larger-than-expected loss and lower-than-expected revenue for the first quarter. Report

Medical Device News

@FierceMedDev: Edwards slashes projections despite Q1 growth. Story | Follow @FierceMedDev

@MarkHFierce: Some breaking news about a French device maker at BIO in Chicago. Article | Follow @MarkHFierce

 @DamianFierce: GE's diagnostics imaging is in high demand, and now the company's teaming up with Eisai on Alzheimer's. More | Follow @DamianFierce

> BIO: French device maker Eveon raising $9.1M for EU, U.S. expansion. Item

> Thermo soars on diagnostics as Life Tech deal pends. More

> GE Healthcare's Pascale Witz seeks better climate for Dx industry growth. Article

Biotech News

@FierceBiotech: Trending on Stem cell transplant heals mouse brains with neurological deficits. More | Follow @FierceBiotech

@RyanMFierce: Israel's Treato, analyzing social for pharma, found $14.5M from OrbiMed, New Leaf and Reed Elsevier. Release | Follow @RyanMFierce

> AstraZeneca, Aussie biotech outfit ally in $240M-plus discovery deal. More

> Merck scores 'breakthrough' status from FDA for immunotherapy against melanoma. Story

> OPKO Health to acquire Prolor Biotech for $480M. Article

Drug Delivery News

@MichaelGFierce: Researchers reverse Parkinson's damage with nasal gene delivery. Article | Follow @MichaelGFierce

> New delivery combo for proven breast cancer drug boosts performance. More

> Bacteria deliver radioactive drugs to treat pancreatic cancer. Story

> AstraZeneca, Bind team up for cancer drug delivery. Item

> Civitas' inhaled Parkinson's drug promises novel delivery with positive PhII results. Article

> Cornell nanosized 'dots' for diagnostics may now deliver drugs. More

And Finally... The Mayo Clinic is spending up to $3.5 billion to go up-market, but it thinks its hometown needs to pitch in, too. Report (sub. req.)